InsidersTradesSigma
PuraPharm Corporation Ltd.: directors' dealings · Hong Kong · HKEX
HKEX:purapharm-corporation-ltdHK·HKEXMcap 155M€Healthcare
Explore the full insider trade history of PuraPharm Corporation Ltd., a listed equity based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, PuraPharm Corporation Ltd. has logged 1 insider filings. Market capitalisation: €155.2m. The latest transaction was reported on 11 May 2026 — Other. Among the most active insiders: Ng Wang Wai Charles. The full history is accessible without an account.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.29 €
Analyst consensus
Income statement
Revenue336.1 M€
Gross profit180.2 M€54% margin
Net income−35.2 M€-10.5% margin
Valuation
P/Book1.2x
Beta0.21
Balance sheet & cash
Market cap155.2 M€
Total debt351.1 M€
Free Cash Flow25.7 M€
Debt / Equity269%
Profitability & ownership
ROE-29.1%
ROA-1.4%
% insiders65.3%
% institutions0.0%
Last declaration on 11 May 2026
Declarations1 total
1 of 1 declaration